A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : PLGA

Search Conditions:
Search Keyword : PLGA
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: PLGA
Appearance Frequency: 4842 time(s)
Long forms: 76

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
poly(lactic-co-glycolic acid)
(4541 times)
Pharmacology
(1259 times)
NPs (387 times)
PLA (194 times)
PEG (189 times)
1986 Prolonged controlled-release of nafarelin, a luteinizing hormone-releasing hormone analogue, from biodegradable polymeric implants: influence of composition and molecular weight of polymer.
polymorphous low-grade adenocarcinoma
(135 times)
Pathology
(43 times)
ACC (34 times)
PA (22 times)
MEC (12 times)
1988 Polymorphous low-grade adenocarcinoma of minor salivary gland. An immunohistochemical and clinicopathologic study.
poly(L-glutamic acid)
(60 times)
Chemistry
(20 times)
PLL (17 times)
LbL (6 times)
WSC (4 times)
1984 Antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugated with polyglutamic acid and its derivative.
acid-polyglycolic acid copolymer
(6 times)
General Surgery
(2 times)
BM-MSCs (2 times)
NPs (2 times)
BMD (1 time)
2000 [Uptake of drug-containing nanoparticles in dog catotid and femoral arteries].
poly(alpha-L-glutamic acid)
(6 times)
Chemistry
(3 times)
LB (2 times)
CD (1 time)
DHFR (1 time)
1989 Conformational transition of poly(alpha-L-glutamic acid). A polyelectrolytic approach.
poly-l-lactic-co-glycolic acid
(5 times)
Biomedical Engineering
(2 times)
beta-TCP (1 time)
BMSCs (1 time)
FA (1 time)
2010 Effect of ceramic filler content on the mechanical and thermal behaviour of poly-L-lactic acid and poly-L-lactic-co-glycolic acid composites for medical applications.
poly(glycolic-lactic acid)
(4 times)
Biomedical Engineering
(2 times)
ALT (1 time)
DDS (1 time)
GMO (1 time)
2009 The influence of side group modification in polyphosphazenes on hydrolysis and cell adhesion of blends with PLGA.
Poly(Lactic⁻co⁻Glycolic)
(4 times)
Polymers
(1 time)
HA (2 times)
CIC (1 time)
2017 In Vitro and in Vivo Study of Poly(Lactic⁻co⁻Glycolic) (PLGA) Membranes Treated with Oxygen Plasma and Coated with Nanostructured Hydroxyapatite Ultrathin Films for Guided Bone Regeneration Processes.
coated-poly-lactide-co-glycolide
(3 times)
Biomedical Engineering
(2 times)
ALP (1 time)
BMP-2 (1 time)
CLSM (1 time)
2008 Homogeneous chitosan-PLGA composite fibrous scaffolds for tissue regeneration.
10  poly(glycolide-co-L-lactide)
(3 times)
Biomedical Engineering
(1 time)
ADM (1 time)
CS (1 time)
GM-CSF (1 time)
1997 Characterization of poly(glycolide-co-D,L-lactide)/poly(D,L-lactide) microspheres for controlled release of GM-CSF.
11  polyglycolide acid
(3 times)
Dentistry
(3 times)
CAL (1 time)
CTG (1 time)
ePTFE (1 time)
2003 Comparative clinical study of connective tissue graft and two types of bioabsorbable barriers in the treatment of localized gingival recessions.
12  acid-polyglycolic acid
(2 times)
Histology
(1 time)
PGA (1 time)
PLA (1 time)
2001 In vitro organization of biohybrid rat liver tissue incorporating growth factor- and hormone-releasing biodegradable polymer microcapsules.
13  alginate-chitosan-poly(lactic-co-glycolic acid)
(2 times)
Pharmacology
(1 time)
BSA (1 time)
HBsAg (1 time)
2004 A protein delivery system: biodegradable alginate-chitosan-poly(lactic-co-glycolic acid) composite microspheres.
14  pediatric low-grade astrocytoma
(2 times)
Neoplasms
(2 times)
NF1 (1 time)
PFS (1 time)
2011 BRAF-KIAA1549 fusion predicts better clinical outcome in pediatric low-grade astrocytoma.
15  PLGA polymer solubilized in N-methyl pyrrolidone
(2 times)
Pharmacology
(1 time)
IM (1 time)
PVD (1 time)
2011 Sustained release formulations of rhVEGF₁₆₅ produce a durable response in a murine model of peripheral angiogenesis.
16  poly(glycolic acid-co-dl-lactic acid)
(2 times)
Pharmacology
(2 times)
--- 2000 In vitro and in vivo characterization of biodegradable enoxacin microspheres.
17  polyglycolic and polylactic acid
(2 times)
General Surgery
(2 times)
PLA (1 time)
PTH (1 time)
2003 Experimental study on the adhesion, migration and three-dimensional growth of Schwann cells on absorbable biological materials.
18  Polymorphous low-grade adenocarcinoma of salivary gland origin
(2 times)
Medicine
(1 time)
--- 1999 Histologic transformation of polymorphous low-grade adenocarcinoma of salivary gland.
19  (R-PLGA, equivalent to 1.03-1.72 mg/kg) or polymer microparticles alone
(1 time)
Pharmacology
(1 time)
Mtb (1 time)
2001 Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: screening in an infectious disease model.
20  biotin-PEG-poly(lactic-co-(glycolic acid))
(1 time)
Biochemistry
(1 time)
PEG (1 time)
PLA (1 time)
PTMC (1 time)
2006 PEG-PLA block copolymer as potential drug carrier: preparation and characterization.
21  deslorelin-poly(lactide-co-glycolide)
(1 time)
Pharmacology
(1 time)
HP-beta-CD (1 time)
2004 Pulmonary delivery of deslorelin: large-porous PLGA particles and HPbetaCD complexes.
22  nano-hydroxyapatite-polylactide- co-glycolide
(1 time)
Nanotechnology
(1 time)
MSC (1 time)
2011 Nanomaterials enhance osteogenic differentiation of human mesenchymal stem cells similar to a short peptide of BMP-7.
23  nanoparticle-poly(lactic-co-glycolic acid)
(1 time)
Pharmacology
(1 time)
--- 1997 A novel biodegradable system based on gelatin nanoparticles and poly(lactic-co-glycolic acid) microspheres for protein and peptide drug delivery.
24  paclitaxel-loaded polylactide-co-glycolide
(1 time)
Biomedical Engineering
(1 time)
--- 2010 The use of submicron/nanoscale PLGA implants to deliver paclitaxel with enhanced pharmacokinetics and therapeutic efficacy in intracranial glioblastoma in mice.
25  particles were encapsulated into DL-lactide/glycolide copolymer
(1 time)
Pharmacology
(1 time)
BSA (1 time)
PLA (1 time)
SEM (1 time)
2005 Uniform encapsulation of stable protein nanoparticles produced by spray freezing for the reduction of burst release.
26  PEGylated-doxorubicin(DOX)-loaded-poly-lactic-co-glycolic acid
(1 time)
Chemical Phenomena
(1 time)
DOX (1 time)
DOXHCl (1 time)
IS (1 time)
2018 Enhancement of oral bioavailability of doxorubicin through surface modified biodegradable polymeric nanoparticles.
27  phenomenon, three commercially available D,L-lactic acid-co-glycolic acid
(1 time)
Pharmacology
(1 time)
ISFIs (1 time)
LA (1 time)
2009 Changes in morphology of in situ forming PLGA implant prepared by different polymer molecular weight and its effect on release behavior.
28  PLA-PEG and lactic acid--glycolic acid copolymer
(1 time)
General Surgery
(1 time)
BMP (1 time)
PLA-PEG (1 time)
1993 Bone induction and bone repair by composites of bone morphogenetic protein and biodegradable synthetic polymers.
29  PLA-PGA
(1 time)
GO (1 time)
nHA (1 time)
PCL (1 time)
2019 Synthetic Biodegradable Aliphatic Polyester Nanocomposites Reinforced with Nanohydroxyapatite and/or Graphene Oxide for Bone Tissue Engineering Applications.
30  PLGA scaffolds without cells
(1 time)
Dermatology
(1 time)
alpha-SMA (1 time)
FB (1 time)
GFP (1 time)
2018 Three-dimensional poly lactic-co-glycolic acid scaffold containing autologous platelet-rich plasma supports keloid fibroblast growth and contributes to keloid formation in a nude mouse model.
31  PLGA-Chi
(1 time)
Chemistry
(1 time)
alpha-T (1 time)
TRF (1 time)
2015 Cellular uptake, antioxidant and antiproliferative activity of entrapped alpha-tocopherol and gamma-tocotrienol in poly (lactic-co-glycolic) acid (PLGA) and chitosan covered PLGA nanoparticles (PLGA-Chi).
32  PLGA-CsA
(1 time)
Neoplasms
(1 time)
DOX (1 time)
FACS (1 time)
P-gp (1 time)
2014 Enhanced activity of doxorubicin in drug resistant A549 tumor cells by encapsulation of P-glycoprotein inhibitor in PLGA-based nanovectors.
33  PLGA-DOX-CsA
(1 time)
Neoplasms
(1 time)
DOX (1 time)
FACS (1 time)
P-gp (1 time)
2014 Enhanced activity of doxorubicin in drug resistant A549 tumor cells by encapsulation of P-glycoprotein inhibitor in PLGA-based nanovectors.
34  PLGA-fluvastatin
(1 time)
Dentistry
(1 time)
GBR (1 time)
2019 Generation and histomorphometric evaluation of a novel fluvastatin-containing poly(lactic-co-glycolic acid) membrane for guided bone regeneration.
35  PLGA-scaffolds
(1 time)
Medicine
(1 time)
ASCs (1 time)
SD (1 time)
2014 Periodontal tissue regeneration by transplantation of rat adipose-derived stromal cells in combination with PLGA-based solid scaffolds.
36  PLGA/GO
(1 time)
Biocompatible Materials
(1 time)
BDNF (1 time)
GO (1 time)
IGF-1 (1 time)
2019 Graphene oxide-PLGA hybrid nanofibres for the local delivery of IGF-1 and BDNF in spinal cord repair.
37  PLGA/PBMP
(1 time)
Biomedical Engineering
(1 time)
HA (1 time)
PBMP (1 time)
QS (1 time)
2019 Calcium-Binding Polymer-Coated Poly(lactide- co-glycolide) Microparticles for Sustained Release of Quorum Sensing Inhibitors to Prevent Biofilm Formation on Hydroxyapatite Surfaces.
38  PLGA4-7 LPNs
(1 time)
Biomedical Engineering
(1 time)
LPNs (1 time)
mRNA (1 time)
TT (1 time)
2018 Lipid Polymer Hybrid Nanomaterials for mRNA Delivery.
39  PLGAac
(1 time)
Chemistry
(1 time)
PCL (1 time)
2012 Biomolecule gradient in micropatterned nanofibrous scaffold for spatiotemporal release.
40  PLGAes
(1 time)
Chemistry
(1 time)
PCL (1 time)
2012 Biomolecule gradient in micropatterned nanofibrous scaffold for spatiotemporal release.
41  poly L-lactide/D-lactide/glycolide
(1 time)
General Surgery
(1 time)
CTGF (1 time)
GAG (1 time)
hUCMSCs (1 time)
2013 Effects of connective tissue growth factor on the regulation of elastogenesis in human umbilical cord-derived mesenchymal stem cells.
42  poly(alpha,L-glutamate)
(1 time)
Polymers
(1 time)
LC (1 time)
PHBG-P1 (1 time)
2000 Thermal and structural properties of biologically derived monodisperse hairy-rod polymers.
43  poly(D,L-lactide-co-glycolide) microparticles
(1 time)
Dentistry
(1 time)
ACS (1 time)
DBM (1 time)
rhBMP-2 (1 time)
1996 Periodontal repair in dogs: evaluation of rhBMP-2 carriers.
44  poly(glycolide)-based
(1 time)
Biomedical Engineering
(1 time)
CMs (1 time)
PLLA (1 time)
SEM (1 time)
2005 Electrospun fine-textured scaffolds for heart tissue constructs.
45  poly(glycolide-co-lactide) copolymer
(1 time)
Biomedical Engineering
(1 time)
PGA (1 time)
PLA (1 time)
2009 Preparation of biodegradable PLA/PLGA membranes with PGA mesh and their application for periodontal guided tissue regeneration.
46  poly(lactic-co-glycolic acid)/fibrin gel
(1 time)
Orthopedics
(1 time)
IVD (1 time)
PG (1 time)
2017 Effects of annulus defects and implantation of poly(lactic-co-glycolic acid) (PLGA)/fibrin gel scaffolds on nerves ingrowth in a rabbit model of annular injury disc degeneration.
47  Poly(lactic-co-glycolic acid):Poly(ethylene oxide)
(1 time)
Biomedical Engineering
(1 time)
PEO (1 time)
2016 Hybrid Randomly Electrospun Poly(lactic-co-glycolic acid):Poly(ethylene oxide) (PLGA:PEO) Fibrous Scaffolds Enhancing Myoblast Differentiation and Alignment.
48  poly-L: -lactate-glycolic acid copolymer
(1 time)
Biotechnology
(1 time)
IGF (1 time)
MSCs (1 time)
TGF (1 time)
2005 Differentiation of Human Bone Marrow Mesenchymal Stem Cells to Chondrocytes for Construction of Three-dimensional Cartilage Tissue.
49  polyarylate and a fast-degrading copolymer of lactic and glycolic acid
(1 time)
Pharmacology
(1 time)
--- 2002 A synthetic polymer matrix for the delayed or pulsatile release of water-soluble peptides.
50  polyethylenimine-poly(lactide-coglycolide)
(1 time)
Genetics, Medical
(1 time)
EPAS1 (1 time)
VEGF (1 time)
2015 PLGA/poloxamer nanoparticles loaded with EPAS1 siRNA for the treatment of pancreatic cancer in vitro and in vivo.
51  polyglucuronic acid
(1 time)
Biomedical Engineering
(1 time)
GAG (1 time)
2004 Effect of poly DL-lactic-co-glycolic acid mesh on a three-dimensional culture of chondrocytes.
52  polyglycolic acid and polylactide
(1 time)
Complementary Therapies
(1 time)
--- 2005 [Blood vessel tissue engineering: seeding vascular smooth muscle cells and endothelial cells sequentially on biodegradable scaffold in vitro].
53  polyglycolic acid; lactide/glycolide copolymer
(1 time)
Rheumatology
(1 time)
ADM (1 time)
qPCR (1 time)
2013 Attachment, proliferation and collagen type I mRNA expression of human gingival fibroblasts on different biodegradable membranes.
54  polyglycolid-polylactid
(1 time)
Dentistry
(1 time)
HU (1 time)
2007 Bone formation after sinus augmentation with engineered bone.
55  polylactic/glycolic acid sponge
(1 time)
Orthopedics
(1 time)
ABG (1 time)
CT (1 time)
1997 Augmentation of autograft using rhBMP-2 and different carrier media in the canine spinal fusion model.
56  PolyLactide Glycolide Acid
(1 time)
Dentistry
(1 time)
PLLA (1 time)
2014 [Reaction of bone tissue elements on synthetic bioresorbable materials based on lactic and glycolic acids].
57  polymer and a biodegradable
(1 time)
Eye Diseases
(1 time)
5-FU (1 time)
AGV (1 time)
HEMA (1 time)
2015 Effect of Two Novel Sustained-Release Drug Delivery Systems on Bleb Fibrosis: An In Vivo Glaucoma Drainage Device Study in a Rabbit Model.
58  polymer of glycolide and lactide
(1 time)
Biomedical Engineering
(1 time)
IM (1 time)
LNG (1 time)
s.c (1 time)
2000 [Studies on the toxicity of polymer of glycolide and lactide(PLGA) and the anti-fertility effect of levonorgestrel(LNG)].
59  polymer of lactic and glycolic acid
(1 time)
Allergy and Immunology
(1 time)
--- 2006 Biodegradable PLGA particles for improved systemic and mucosal treatment of Type I allergy.
60  polymeric biodegradable lactic-glycolic acid
(1 time)
Allergy and Immunology
(1 time)
EAE (1 time)
IFN (1 time)
IL (1 time)
2014 Subcutaneous inverse vaccination with PLGA particles loaded with a MOG peptide and IL-10 decreases the severity of experimental autoimmune encephalomyelitis.
61  Polymeric MP with D, L-lactic-co-glycolic acid
(1 time)
Chemistry
(1 time)
MP (1 time)
2018 Effect of excipients on encapsulation and release of insulin from spray-dried solid lipid microparticles.
62  posterior branch of the left gastric artery
(1 time)
Gastroenterology
(1 time)
LGA (1 time)
RGEA (1 time)
1990 [Relation between localization of gastric mucosal lesions and microvascular disturbance].
63  potentials, with a bio-adhesive agent -polylactic-co-glycolic acid
(1 time)
Complementary Therapies
(1 time)
NHMC (1 time)
PCNA (1 time)
PDI (1 time)
2010 Polymeric nanoparticle encapsulation of a naturally occurring plant scopoletin and its effects on human melanoma cell A375.
64  precise compositional analysis of copoly (DL-lactic/glycolic acid)
(1 time)
Chemistry
(1 time)
TMAH (1 time)
2001 Compositional analysis of copoly (DL-lactic/glycolic acid) (PLGA) by pyrolysis-gas chromatography/mass spectrometry combined with one-step thermally assisted hydrolysis and methylation in the presence of tetramethylammonium hydroxide.
65  prepared from copolymers of lactic and glycolic acid
(1 time)
Pharmacology
(1 time)
--- 2009 A new class of inhibitors of peptide sorption and acylation in PLGA.
66  prepared from dl-lactide/glycolide copolymers
(1 time)
Chemistry
(1 time)
--- 2007 Improved bioavailability of orally administered mifepristone from PLGA nanoparticles.
67  present study evaluated the size-dependency of DL lactide/glycolide copolymer
(1 time)
Pharmacology
(1 time)
FA-PLGA (1 time)
2002 Size-dependency of DL-lactide/glycolide copolymer particulates for intra-articular delivery system on phagocytosis in rat synovium.
68  previous work demonstrated that lactic/glycolic acid copolymer
(1 time)
Chemistry
(1 time)
SLN (1 time)
2009 The effect of glycolic acid monomer ratio on the emulsifying activity of PLGA in preparation of protein-loaded SLN.
69  Previously synthesized lactic/glycolic acid
(1 time)
Biomedical Engineering
(1 time)
--- 1997 Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid oligomers: Part II. Biodegradation and drug delivery application.
70  previously-synthesized lactic/glycolic acid polymers
(1 time)
Biomedical Engineering
(1 time)
--- 2001 Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid polymers. Part II: biodegradation.
71  procedures using solvent-casting techniques with the same copoly(D,L-lactic) glycolic acid
(1 time)
Chemistry
(1 time)
D,L-lactic (1 time)
rhGH (1 time)
2006 A mathematical model for interpreting in vitro rhGH release from laminar implants.
72  prolonged anti-inflammatory action of DL-lactide/glycolide copolymer
(1 time)
Pharmacology
(1 time)
LA/GA (1 time)
PBS (1 time)
2002 Prolonged anti-inflammatory action of DL-lactide/glycolide copolymer nanospheres containing betamethasone sodium phosphate for an intra-articular delivery system in antigen-induced arthritic rabbit.
73  proper copoly(DL-lactic/glycolic)acid
(1 time)
Pharmacology
(1 time)
rhGH (1 time)
2003 Sustained release of human growth hormone from microcapsules prepared by a solvent evaporation technique.
74  property on drug release, a novel reduction-sensitive amphiphilic copolymer
(1 time)
Nanotechnology
(1 time)
DTX (1 time)
2015 Effects of X-shaped reduction-sensitive amphiphilic block copolymer on drug delivery.
75  Pulmonary delivery of insulin with nebulized DL-lactide/glycolide copolymer
(1 time)
Pharmacology
(1 time)
--- 1999 Pulmonary delivery of insulin with nebulized DL-lactide/glycolide copolymer (PLGA) nanospheres to prolong hypoglycemic effect.
76  rapamycin-polylactide-co-glycolide
(1 time)
Complementary Therapies
(1 time)
--- 2007 [Pharmacodynamics of China-made rapamycin-polylactide-co-glycolide peripheral arterial eluting stent membrane: in vitro experiment].